Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMC

Development of 3D-printed PLGA/TiO 2 nanocomposite scaffolds for bone tissue engineering applications

Rasoulianboroujeni M., Fahimipour F., Shah P., Khoshroo K., Tahriri M., Eslami H.

Laboratory Study on Face & Skin, published in Mater Sci Eng C Mater Biol Appl (2019) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Mater Sci Eng C Mater Biol Appl (2019)
Reported sample size
—
Source database
Europe PMC
PMID
30606516
PMCID
PMC6388694
DOI
10.1016/j.msec.2018.10.077
Citations
56

Abstract (original English)

Porous scaffolds were 3D-printed using poly lactic-co-glycolic acid (PLGA)/TiO 2 composite (10:1 weight ratio) for bone tissue engineering applications. Addition of TiO 2 nanoparticles improved the compressive modulus of scaffolds. Differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA) revealed an increase in both glass transition temperature and thermal decomposition onset of the composite compared to pure PLGA. Furthermore, addition of TiO 2 was found to enhance the wettability of the surface evidenced by reducing the contact angle from 90.5 ± 3.2 to 79.8 ± 2.4 which is in favor of cellular attachment and activity. The obtained results revealed that PLGA/TiO 2 scaffolds significantly improved osteoblast proliferation compared to pure PLGA (p 2 nanocomposite showed significantly higher ALP activity and improved calcium secretion compared to pure PLGA scaffolds (p < 0.05).

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Cell LineHumansTitaniumTissue EngineeringMaterials TestingWettabilityNanocompositesTissue ScaffoldsPrinting, Three-DimensionalPolylactic Acid-Polyglycolic Acid Copolymer

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research